Secondary Hemophagocytic Lymphohistiocytosis Clinical Trials

7 clinical trials for Secondary Hemophagocytic Lymphohistiocytosis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 2/3, Open-label, Single-arm, Multicenter, Historical Control Study to Evaluate ELA026 in Participants with Secondary Hemophagocytic Lymphohistiocytosis (sHLH) — RECRUITING · PHASE3
• Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) — RECRUITING · PHASE2
• Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study — RECRUITING
• Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis — COMPLETED
• Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE — COMPLETED · PHASE3
• Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients — OTHER
• Rituximab Monotherapy for EBV-HLH and CAEBV — OTHER · PHASE3

Refine this search